Piper Sandler Cuts Inari to Neutral; Cites Slowing Growth, DOJ Probe
Needham Starts Inari at Buy, Citing Improving Operating Margins
Analysts Have Conflicting Sentiments on These Healthcare Companies: Definitive Healthcare Corp (DH), Anavex Life Sciences (AVXL) and Inari Medical (NARI)
Analysts Offer Insights on Healthcare Companies: Merus (MRUS), 4D Molecular Therapeutics (FDMT) and Inari Medical (NARI)
Analysts Offer Insights on Healthcare Companies: BioMarin Pharmaceutical (BMRN), Inari Medical (NARI) and Nevro Corp (NVRO)
No Data